Francisco Ayala (Francisco Ayala de la Peña, F Ayala de la Pena, F Ayala de la Peña)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cancers

PloS one

University of Murcia (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Murcia

Spain

PHD :: Internal Medicine

University of Murcia

Spain

PHD :: Internal Medicine

Publications

Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast cancer research and treatment 205 (3) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment (2024)
Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast cancer research and treatment 205 (3) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast cancer research and treatment 205 (3) (2024)
Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast cancer research and treatment 205 (3) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast cancer research and treatment (2024)
Francisco Ayala, Silvia Antolin Novoa, Joaquín Gavilá, Lucía González Cortijo, Fernando Henao, María Teresa Martínez Martínez, Cristina Morales Estévez, Agostina Stradella, María Jesús Vidal Losada, Eva Ciruelos Gil
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Francisco Ayala, Silvia Antolin Novoa, Joaquín Gavilá, Lucía González Cortijo, Fernando Henao, María Teresa Martínez Martínez, Cristina Morales Estévez, Agostina Stradella, María Jesús Vidal Losada, Eva Ciruelos Gil
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Esmeralda García-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro-Manzano, Noel Blaya Boluda, Pilar de la Morena Barrio, Elisa García-Garre, Francisco Martínez Díaz, Asunción Chaves-Benito, Elena García-Martínez, Francisco Ayala
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer. Cancers 15 (10) (2023)
Esther Navarro-Manzano, Ginés Luengo-Gil, Rocío González-Conejero, Elisa García-Garre, Elena García-Martínez, Esmeralda Garcia Torralba, Asunción Chaves-Benito, Vicente Vicente, Francisco Ayala
Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer. Cancers 14 (10) (2022)
Karama Asleh, Ana Lluch, Angela Goytain, Carlos Henrique Barrios, Xue Qi Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz Borrego, Samuel C Y Leung, Jose Bines, Angel L Guerrero-Zotano, José Angel García-Saenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres, Juan R De la Haba-Rodríguez, Francisco Ayala, Henry L Gómez, Federico Rojo, Torsten O Nielsen, Miguel Martin
Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Francisco Ayala, B Ortiz-Muñoz, T Quintanar-Verdúguez, J D Santotoribio, S de la Cruz, J Trapé-Pujol, E Galve-Calvo, J M Augé-Fradera, J García-Gómez, Á González-Hernández
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (7) (2021)
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buque, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro-Manzano, Francisco Ayala, Elena García-Martínez, Sylvia C Formenti, Zlatko Trajanoski, Lorenzo Galluzzi
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology 21 (10) (2020)
Ginés Luengo-Gil, Elena García-Martínez, Asunción Chaves-Benito, Pablo Conesa-Zamora, Esther Navarro-Manzano, Enrique González-Billalabeitia, Elisa García-Garre, Alberto Martínez-Carrasco, Vicente Vicente, Francisco Ayala
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cellular oncology (Dordrecht) 42 (5) (2019)
Gines Luengo-Gil, Enrique Gonzalez-Billalabeitia, Sergio Alejo Perez-Henarejos, Esther Navarro Manzano, Asuncion Chaves-Benito, Elena Garcia-Martinez, Elisa Garcia-Garre, Vicente Vicente, Francisco Ayala
Angiogenic role of miR-20a in breast cancer. PloS one 13 (4) (2018)
Elisa García Garre, Ginés Luengo Gil, Silvia Montoro García, Enrique Gonzalez Billalabeitia, Marta Zafra Poves, Elena García Martinez, Vanessa Roldán Schilling, Esther Navarro Manzano, Alejandra Ivars Rubio, Gregory Y H Lip, Francisco Ayala
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. Breast cancer research and treatment 169 (1) (2018)
Francisco Ayala, R Andrés, J A Garcia-Sáenz, L Manso, M Margelí, E Dalmau, S Pernas, A Prat, S Servitja, E Ciruelos
SEOM clinical guidelines in early stage breast cancer (2018). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (1) (2018)
A Carmona-Bayonas, P Jimenez-Fonseca, E M de Castro, E Mata, M Biosca, A Custodio, J Espinosa, E G Vázquez, F Henao, Francisco Ayala
SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (1) (2018)

Francisco Ayala.css-eqlu8i{font-size:small;padding-left:4px;} (Francisco Ayala de la Peña, F Ayala de la Pena, F Ayala de la Peña)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Ayala (Francisco Ayala de la Peña, F Ayala de la Pena, F Ayala de la Peña)